The Westin Miyako Kyoto
Delivered as a Hybrid Event
Presented in Japan Standard Time
The Westin Miyako Kyoto
Delivered as a Hybrid Event
Book Early For Best Rates!
ASIA’S LEADING CONFERENCE TO ACCELERATE ANTIBODY/PROTEIN THERAPEUTICS, ADC’s, BISPECIFICS & IMMUNO-ONCOLOGY
Bringing together the antibody/protein therapeutic community to share advances in antibody discovery & engineering, bi/multispecific antibodies, ADCs, immuno-oncology & AI/ML-enabled applications
Select the right antibody, move faster towards IND, and apply clinical learnings from real-world case studies.
Featured Speakers and Keynotes!
Key Antibody Research, Cutting-Edge Technology, and Unrivaled Networking Opportunities
Case Studies & New Data Breaking Down:
- Bispecific and Multispecific Antibodies
- Antibodies for Novel/Challenging Targets
- Immune Cell Engager Antibody Technologies
- Antibody-Drug Conjugates
- Disease-Area Specific Antibodies
Lessons Learned From Antibody Programs:
- AI/Machine Learning for Antibody Developability
- New Binders, Therapeutic Modalities & Antibody Formats
- Agonist Antibodies and Conditional Antibodies
- Novel Antibody Technologies and Applications
- Preclinical and Clinical Antibody Case Studies
The Return to Japan in 2024:
After a break for 3 years, we are pleased to announce the return to Japan in October 2024. Join pioneers in the antibody community as they dive into the critical updates within the industry. You'll have the opportunity to network with peers from across the globe in the vibrant city of Kyoto - renowned for developing many of the refined arts that are now associated with Japan.
CONNECT WITH KEY BUYERS AT Antibody Asia 2024 in Kyoto
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact Blake Shuka to find out you can get involved:
BShuka@informaconnectls.com | (+1) 212-600-3451